Exceptional Response to Pembrolizumab and Trastuzumab in a Heavily Pretreated Patient With HER2-Positive TMB-H and MSI-H Metastatic Breast Cancer. (2021)

Record Type:: Journal Article
Title:: Exceptional Response to Pembrolizumab and Trastuzumab in a Heavily Pretreated Patient With HER2-Positive TMB-H and MSI-H Metastatic Breast Cancer. (2021)
Main Title:: Exceptional Response to Pembrolizumab and Trastuzumab in a Heavily Pretreated Patient With HER2-Positive TMB-H and MSI-H Metastatic Breast Cancer
Authors:: Li, Allen
Goodyear, Shaun
Fuss, Cristina
Mitri, Zahi
Abstract:
Is Part Of:: JCO precision oncology. Volume 5(2021)
Journal:: JCO precision oncology
Issue:: Volume 5(2021)
Issue Display:: Volume 5, Issue 2021 (2021)
Year:: 2021
Volume:: 5
Issue:: 2021
Issue Sort Value:: 2021-0005-2021-0000
Page Start:
Page End:
Publication Date:: 2021
Subjects:: Precision Medicine
Neoplasms
Pharmacogenetics
Molecular Targeted Therapy
Personalized medicine
Oncology
Pharmacogenomics
Periodical
Periodicals
616.994
Journal URLs:: http://po.jco.org ↗
http://journals.lww.com/pages/default.aspx ↗
DOI:: 10.1200/PO.20.00361 ↗
Languages:: English
ISSNs:: 2473-4284
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 22882.xml